MRNA
MRNA
NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$51.34
+0.06 (+0.12%)
As of Mar 24, 9:41 PM ET ·
Analyst Consensus
Hold
30
Analysts
Very High
Coverage
Buy 3 10%
Hold 21 70%
Sell 6 20%
Price Target
Analyst Price Target +191.1% upside
Low Target $89.97
Average Target $149.45
High Target $212.09
Current Price $51.34
Current
$51.34
Target
$149.45
$89.97 $149.45 avg $212.09
Scenario Analysis
Bear Case
$89.97
75.2%
Low target
Base Case
$149.45
+191.1%
Avg target
Bull Case
$212.09
+313.1%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$55.20
-7.0% from high
52-Week Low
$22.28
+130.4% from low
50-Day SMA
$37.98
+35.2% vs SMA
200-Day SMA
$29.64
+73.2% vs SMA
RSI (14)
57.2
Neutral
Target vs 52W High
$149.45
+170.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%